Invention Grant
- Patent Title: Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans- (+)-Δ9-tetrahydrocannabinol
-
Application No.: US15061859Application Date: 2016-03-04
-
Publication No.: US09675581B2Publication Date: 2017-06-13
- Inventor: Arie L. Gutman , Marina Etinger , Irina Fedotev , Ram Khanolkar , Gennady A. Nisnevich , Boris Pertsikov , Igor Rukhman , Boris Tishin
- Applicant: SVC Pharma LP
- Applicant Address: US NY Spring Valley
- Assignee: SVC Pharma LP
- Current Assignee: SVC Pharma LP
- Current Assignee Address: US NY Spring Valley
- Agency: Dechert LLP
- Main IPC: A61K31/352
- IPC: A61K31/352 ; C07D311/80 ; A61K9/48

Abstract:
Methods for making trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol are disclosed herein. In one embodiment, a trans-(−)-Δ9-tetrahydrocannabinol composition is prepared by allowing a composition comprising (±)-Δ9-tetrahydrocannabinol to separate on a chiral stationary phase to provide a trans-(−)-Δ9-tetrahydrocannabinol composition comprising at least about 99% by weight of trans-(−)-Δ9-tetrahydrocannabinol based on the total amount of trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol. The invention also relates to methods for treating or preventing a condition such as pain comprising administering to a patient in need thereof an effective amount of a trans-(−)-Δ9-tetrahydrocannabinol having a purity of at least about 98% based on the total weight of cannabinoids.
Public/Granted literature
- US20160184261A1 METHODS FOR PURIFYING TRANS-(-)-DELTA9-TETRAHYDROCANNABINOL AND TRANS-(+)-DELTA9-TETRAHYDROCANNABINOL Public/Granted day:2016-06-30
Information query